The success of Viagra initially fueled a boom for major pharmaceutical companies, but recent shifts present a complicated picture for shareholders. Lower-cost alternatives are eating into revenue, and continued https://anyamvkg349069.mybuzzblog.com/21267757/sildenafil-and-pharma-a-precarious-play